Published in AIDS Weekly, March 10th, 1997
Originally introduced in 1986, Gamimune N has continuously maintained a safety record of no documented cases of viral transmission in more than 1.9 million calculated doses.
The use of solvent/detergent treatment provides an additional safety step in Gamimune N's plasma viral removal/inactivation process. The announcement was made at the joint meeting of the American Academy of Allergy, Asthma, and Immunology, the American Association of Immunologists, and the Clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.